homocysteine has been researched along with 9-deoxy-delta-9-prostaglandin d2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aru, GM; Mujumdar, VS; Tummalapalli, CM; Tyagi, SC | 1 |
| Hunt, MJ; Tyagi, SC | 1 |
2 other study(ies) available for homocysteine and 9-deoxy-delta-9-prostaglandin d2
| Article | Year |
|---|---|
Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR.
Topics: Antineoplastic Agents; Aorta; Cell Culture Techniques; Clofibric Acid; Collagen; Culture Media, Serum-Free; Disintegrins; Endothelium, Vascular; Fibric Acids; Homocysteine; Humans; Metalloendopeptidases; Muscle, Smooth; Peroxisome Proliferators; Platelet Aggregation Inhibitors; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2002 |
Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation.
Topics: Animals; Binding, Competitive; Cells, Cultured; Clofibric Acid; Dose-Response Relationship, Drug; Endocardium; Endothelium, Vascular; Fibric Acids; Homocysteine; Intercellular Adhesion Molecule-1; Ligands; Matrix Metalloproteinases; Mice; Myocardium; Prostaglandin D2; Protein Conformation; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2002 |